How soon after clearance does a 510(k) appear in the public record?

FDA publishes cleared 510(k)s on a rolling basis, typically within days to a few weeks of the decision date. Databases built on openFDA — including this one — inherit an additional lag from FDA's own data releases, so treat the public record as reliably current to within a few weeks, not to the day.

Does a new clearance mean the product is launching?

No. Clearance is a regulatory milestone, not a launch announcement. Companies clear devices months or years before launch, clear variants they never ship, and sometimes clear defensively. A clearance tells you the capability and the intent existed at filing time; pair it with commercial signals before concluding a launch is imminent.

Can I see what a competitor has filed but not yet cleared?

No. Pending 510(k) submissions are confidential — the public record only shows decisions. The closest leading indicators are indirect: clearance cadence, registration and listing changes, and the company's own regulatory-heavy job postings or investor statements.

Why do a competitor's devices show up under several company name variants?

Because applicants file under the exact legal-entity string they choose per submission, and FDA does not consolidate them. Acquisitions, subsidiaries, and simple inconsistency scatter one company across multiple names. This site groups known variants on each company page, but for full coverage check for sister entities — especially after M&A.

What does it mean when a competitor clears under a product code they never used before?

It is one of the stronger signals in the record: entry into a new device category, since the code encodes intended use and technology type. Read the actual summary before acting on it — the new code sometimes reflects a reclassified accessory rather than a genuinely new product line.

By Andrew Weston — Installation Systems Engineer

Monitoring Competitor 510(k) Activity

The 510(k) register is one of the few places a competitor's product pipeline leaves mandatory public footprints. Filings are confidential, but every decision is published — and a company's clearance history, read correctly, tells you what they built, when they considered it ready for regulatory review, and which categories they are moving into. Read incorrectly, it produces confident nonsense. This guide is the correct reading.

What a clearance does and does not signal

A cleared 510(k) proves three things: the device described existed in reviewable form, the company spent real money on it (submission, testing, consulting time), and FDA accepted a substantial-equivalence argument for a specific intended use. It does not prove a launch date, commercial priority, or that the marketed product matches the cleared description exactly. The decision date trails the engineering by many months and often leads the launch by many more. Treat clearances as evidence of direction and investment, never as a release calendar.

The watchlist structure

Competitive monitoring in this data reduces to three page types, watched on a cadence:

Company pages — the who. A competitor's page is their clearance timeline plus their recall history in one place. The two facts worth extracting are cadence (how often they clear anything) and mix (which product codes). A cadence break in either direction is the signal: a quiet company suddenly filing quarterly has funded a program; a prolific filer going silent has cut one.
Product-code pages — the where. Watching a code instead of a company catches entrants you were not tracking — the new applicant names in a code's recent-clearance list are your future competitors introducing themselves. The per-year clearance velocity on these pages tells you whether the category itself is heating up or cooling.
Advisory-panel pages — the weather. Panel-level velocity is background context: whether your whole specialty's filing volume is rising, and which product codes dominate it. Useful quarterly, not weekly.

For the companies and codes that matter most, read the actual 510(k) summaries of new clearances, not just the listing rows. The summary names the predicate — which reveals whose technology they benchmarked against, sometimes yours — and the indications language, where the interesting expansions hide. A "same device, broader population" clearance is strategically louder than a new gadget.

Signals worth acting on

First clearance under a new product code. Category entry. Verify in the summary that it is a real product line, not a reclassified accessory.
A cluster of related clearances in one window. Platform launch pattern — instruments, accessories, and system components filed as a coordinated set.
Your product cited as the predicate. The most direct competitive signal the record offers: someone argued equivalence to you, feature by feature, in a public document.
Indications creep across successive clearances. Sequential filings of the same device family with widening indications map the clinical territory a competitor is claiming, one prong at a time.
Recalls against their cleared base. A competitor's recall is market context, not gossip — it changes what hospitals ask every vendor in the category during the next procurement cycle.

The blind spots

Three structural gaps keep the 510(k) record from being the whole picture. Pending submissions are invisible — you learn about programs only at decision time. PMA and De Novo products do not appear here at all, so a competitor's highest-risk flagship can be entirely absent from their 510(k) history. And company identity is fragmented: filings scatter across legal-entity name variants and subsidiaries, so an acquisition can silently move a pipeline to a name you are not watching. After any M&A event in your category, re-derive your watchlist.

The practical loop: pick the handful of companies and product codes that define your competitive set, check their pages on a monthly cadence (weekly around expected decision windows), read the summary PDF of anything new, and log what you conclude. Email alerts can carry the between-checks load. The record is slow, public, and honest — which makes it the rare competitive-intelligence source you can cite in a board deck without a caveat slide.

Frequently asked questions

How soon after clearance does a 510(k) appear in the public record?: FDA publishes cleared 510(k)s on a rolling basis, typically within days to a few weeks of the decision date. Databases built on openFDA — including this one — inherit an additional lag from FDA's own data releases, so treat the public record as reliably current to within a few weeks, not to the day.
Does a new clearance mean the product is launching?: No. Clearance is a regulatory milestone, not a launch announcement. Companies clear devices months or years before launch, clear variants they never ship, and sometimes clear defensively. A clearance tells you the capability and the intent existed at filing time; pair it with commercial signals before concluding a launch is imminent.
Can I see what a competitor has filed but not yet cleared?: No. Pending 510(k) submissions are confidential — the public record only shows decisions. The closest leading indicators are indirect: clearance cadence, registration and listing changes, and the company's own regulatory-heavy job postings or investor statements.
Why do a competitor's devices show up under several company name variants?: Because applicants file under the exact legal-entity string they choose per submission, and FDA does not consolidate them. Acquisitions, subsidiaries, and simple inconsistency scatter one company across multiple names. This site groups known variants on each company page, but for full coverage check for sister entities — especially after M&A.
What does it mean when a competitor clears under a product code they never used before?: It is one of the stronger signals in the record: entry into a new device category, since the code encodes intended use and technology type. Read the actual summary before acting on it — the new code sometimes reflects a reclassified accessory rather than a genuinely new product line.

Last updated 2026-08-04.